SCHEMBL21055813

SCHEMBL21055813

CNc1nc(NCc2ccccc2)nc2cc(C)ccc12

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ACHE P22303 5/20 0.60
BCHE P06276 4/20 0.60
RAD52 P43351 1/20 0.58
KDM4E B2RXH2 1/20 0.57
ALDH1A1 P00352 1/20 0.57
LMNA P02545 1/20 0.57
MAPT P10636 1/20 0.57
PKM P14618 1/20 0.57
UBE2N P61088 1/20 0.57
KMT2A Q03164 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57
RCE1 Q9Y256 1/20 0.57
APP P05067 4/20 0.56
NTRK1 P04629 1/20 0.53
CASP6 P55212 1/20 0.52
CTNNB1 P35222 4/20 0.52
TCF7L2 Q9NQB0 4/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2590280 0.92 RAD52 (0.70) ACHEBCHERAD52KDM4EALDH1A1
SCHEMBL21055805 0.91 ACHE (0.75) ACHEBCHERAD52KDM4EALDH1A1
SCHEMBL16579894 0.90 ACHE (0.58) ACHEBCHERAD52KDM4EALDH1A1
SCHEMBL16280679 0.86 ACHE (0.80) ACHEBCHERAD52KDM4EALDH1A1
SCHEMBL21118626 0.85 ACHE (0.59) ACHEBCHERAD52KDM4EALDH1A1
SCHEMBL21055807 0.81 BCHE (0.72) ACHEBCHERAD52KDM4EALDH1A1
SCHEMBL21055798 0.80 LMNA (0.59) ACHEBCHERAD52KDM4EALDH1A1
SCHEMBL21055815 0.79 APP (0.59) ACHEBCHEKDM4EALDH1A1APP
SCHEMBL3639768 0.79 RAD52 (0.82) ACHEBCHERAD52KDM4EALDH1A1
SCHEMBL16280680 0.78 BCHE (0.57) ACHEBCHERAD52KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10323007-B1 N2N N4-disubstituted quinazoline-2,4-diamines and uses thereof UNIVERSITY OF SOUTH FLORIDA (US) 2019-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10323007-B1 N2N N4-disubstituted quinazoline-2,4-diamines and uses thereof NQO2, NQO1, NIT2 ACHE 14/4885BCHE 224/4885RAD52 1732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.